An impurity was found in Pfizer’s heart and blood pressure medication Accupril that has led to a recall of several lots of the drug. The contaminant, known as a nitrosamine, can be carcinogenic at high levels and can increase a patient’s risk of developing cancer over time.
Patients are advised against stopping their medication at this time. Rather, those that are concerned that they may have pills from ...
continue reading...
Plaintiffs involved in lawsuits over contamination of a key ingredient in generic heart medications have moved to have their cases consolidated before a federal judge.
Shipments of valsartan, an ingredient in medications used to treat high blood pressure and heart failure, were found to be tainted with a chemical known as NDMA. According to the EPA, NDMA is a possible human carcinogen and is used in ...
continue reading...
When several heart medications were found to be contaminated with varying levels of two compounds that are suspected of being human carcinogens, most reports confidently named valsartan as the culprit. Several lots of medications containing valsartan manufactured primarily in Chinese laboratories were found to contain trace amounts of compounds known as NDMA and NDEA. Subsequent testing lead to recalls being issued in both the United States and Canada while ...
Several medications containing valsartan, a component of generic medications used to treat high blood pressure and heart failure, were found to be tainted with a chemical impurity earlier this summer. The discovery of NDMA in the drug, a chemical used in everything from rocket fuel to fish processing, led to a voluntary recall of several valsartan-based medications in July.
NDMA, or N-nitrosodimethylamine, is listed as a possible human carcinogen with the EPA. And while not all valsartan-based ...
continue reading...
